Last Updated: May 10, 2026

Suppliers and packagers for generic pharmaceutical drug: THIOGUANINE


✉ Email this page to a colleague

« Back to Dashboard


THIOGUANINE

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Waylis Therap THIOGUANINE thioguanine TABLET;ORAL 012429 NDA Waylis Therapeutics LLC 80725-630-25 1 BOTTLE in 1 CARTON (80725-630-25) / 25 TABLET in 1 BOTTLE 2023-05-15
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Suppliers and packagers for generic pharmaceutical drug: THIOGUANINE

Last updated: April 23, 2026

Who Supplies Thioguanine (Active Pharmaceutical Ingredient) and Related Starting Materials?

Thioguanine is a cytotoxic thiopurine used in oncology. For procurement, the practical supply landscape splits into (1) API manufacturers (thioguanine itself) and (2) upstream thioguanine raw-material routes (thioguanine intermediates and nucleobase/thiopurine building blocks).

Which companies supply thioguanine API?

No complete, audit-grade supplier list can be produced from the information available in this chat. A compliant, “hard data” supplier table requires verifiable manufacturer-to-product linkages (for example: current catalog listings, marketing authorization database entries, or batch-release documentation tying a named supplier to “thioguanine” API). This level of sourcing is not present here.

What supplier tiers exist for thioguanine procurement?

A procurement program for thioguanine typically uses these supplier categories:

Supplier tier What they sell What matters for selection
API manufacturer Thioguanine (API) GMP status, DMF/CEP alignment, particle specs, CoA reproducibility
Contract manufacturers API made under contract tech transfer history, assay/impurity profile control
Specialty chemical suppliers Thioguanine intermediates/building blocks route consistency, impurity qualification, traceability
Distributors API sourced from upstream manufacturers lead times, MOQ, documentation completeness (CoA, SDS)

Thioguanine Supply Inputs: What upstream materials are typically sourced?

Thioguanine is a thiopurine nucleobase. Supply due diligence typically extends to upstream inputs such as:

  • Thiopurine nucleobase precursors used to build the thioguanine ring system
  • Sulfur-introduction reagents used in thiopurine routes
  • Purification reagents used to meet thioguanine impurity specifications

No specific named upstream suppliers can be listed without product-linked sourcing evidence.

What proof points a thioguanine sourcing bid should require

Use the same documentation package that regulatory and quality teams expect for cytotoxic APIs:

Proof point Minimum expectation in bids
GMP statement Facility manufacture under GMP for API (or equivalent)
Quality documents CoA for each lot, SDS, impurity report
Compliance file DMF or CEP reference where applicable, or supplier qualification file
Analytical methods Assay and impurities methods or cross-reference
Traceability Batch genealogy and material traceability through receipt-to-use

Market and regulatory context that affects who supplies

Thioguanine is a controlled cytotoxic category in many markets. Supplier availability is shaped by:

  • Oncology-focused GMP capacity
  • Availability of qualified impurity profiles
  • Export documentation for cytotoxic substances
  • Regulatory listing status tied to specific jurisdictions

Operational sourcing checklist (actionable for procurement)

A thioguanine supplier shortlist should be built using a repeatable filter:

  1. API-specific GMP scope covering thioguanine
  2. Documented impurity profile control (identified impurities, limits, and method acceptance)
  3. Lot-to-lot consistency (CoA trends for assay and key impurities)
  4. Supply continuity (back-up lots, alternate manufacturing sites if offered)

Key Takeaways

  • Thioguanine procurement requires API-specific GMP and documentation; distributor-only sourcing without a qualified manufacturer link increases qualification risk.
  • A named supplier list cannot be produced from this chat without verifiable evidence tying specific companies to thioguanine API supply.
  • Build bids around GMP scope, CoA/impurities, compliance file linkage, and traceability rather than catalog claims.

FAQs

  1. Is thioguanine typically sourced from the same companies that supply other thiopurines?
    API supply is often adjacent across thiopurines, but thioguanine production requires product-specific GMP and impurity qualification, so the overlap is not guaranteed.

  2. Do distributors count as suppliers for qualification purposes?
    Distributors can provide product, but qualification usually requires identification and approval of the underlying API manufacturer and documentation traceability.

  3. What quality attributes matter most for cytotoxic thioguanine?
    Assay potency, key impurity identities and limits, and batch-to-batch reproducibility in CoAs.

  4. How do regulatory files affect thioguanine sourcing?
    Where a DMF/CEP exists for thioguanine, it can speed qualification; if not, suppliers may require deeper technical and quality assessment.

  5. What documentation is non-negotiable for thioguanine API?
    Lot CoA, SDS, impurity data, and facility/GMP scope statements that directly cover thioguanine.


References

[1] European Medicines Agency (EMA). European public assessment reports and related regulatory documentation for thioguanine-containing products.
[2] U.S. FDA. Drug master file (DMF) overview and regulatory guidance for API submissions.
[3] WHO. Good manufacturing practices and GMP expectations for pharmaceutical substances.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing